These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 11684212

  • 21. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S.
    Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [Abstract] [Full Text] [Related]

  • 22. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.
    Harms HK, Matouk E, Tournier G, von der Hardt H, Weller PH, Romano L, Heijerman HG, FitzGerald MX, Richard D, Strandvik B, Kolbe J, Kraemer R, Michalsen H.
    Pediatr Pulmonol; 1998 Sep; 26(3):155-61. PubMed ID: 9773909
    [Abstract] [Full Text] [Related]

  • 23. rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease.
    Christopher F, Chase D, Stein K, Milne R.
    J Clin Pharm Ther; 1999 Dec; 24(6):415-26. PubMed ID: 10651974
    [Abstract] [Full Text] [Related]

  • 24. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.
    Shah PI, Bush A, Canny GJ, Colin AA, Fuchs HJ, Geddes DM, Johnson CA, Light MC, Scott SF, Tullis DE.
    Eur Respir J; 1995 Jun; 8(6):954-8. PubMed ID: 7589382
    [Abstract] [Full Text] [Related]

  • 25. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
    Wilmott RW, Amin RS, Colin AA, DeVault A, Dozor AJ, Eigen H, Johnson C, Lester LA, McCoy K, McKean LP, Moss R, Nash ML, Jue CP, Regelmann W, Stokes DC, Fuchs HJ.
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1914-7. PubMed ID: 8665055
    [Abstract] [Full Text] [Related]

  • 26. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL, Auci RM, Shields DE, Christiansen DH, Lucas MK, Fuchs HJ, Rosenstein BJ.
    Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
    [Abstract] [Full Text] [Related]

  • 27. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial.
    Gupta S, Ahmed F, Lodha R, Gupta YK, Kabra SK.
    J Trop Pediatr; 2012 Oct; 58(5):375-81. PubMed ID: 22374985
    [Abstract] [Full Text] [Related]

  • 28. Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis.
    Oster G, Huse DM, Lacey MJ, Regan MM, Fuchs HJ.
    Ann Pharmacother; 1995 May; 29(5):459-64. PubMed ID: 7655127
    [Abstract] [Full Text] [Related]

  • 29. Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
    van der Giessen LJ, Gosselink R, Hop WC, Tiddens HA.
    Eur Respir J; 2007 Oct; 30(4):763-8. PubMed ID: 17596273
    [Abstract] [Full Text] [Related]

  • 30. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
    Chen JJ, Hamilton SA.
    J Biopharm Stat; 2000 Aug; 10(3):287-97. PubMed ID: 10959912
    [Abstract] [Full Text] [Related]

  • 31. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
    Robinson M, Hemming AL, Moriarty C, Eberl S, Bye PT.
    Pediatr Pulmonol; 2000 Jul; 30(1):16-24. PubMed ID: 10862158
    [Abstract] [Full Text] [Related]

  • 32. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF.
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [Abstract] [Full Text] [Related]

  • 33. [Multicenter study of rhDNase in cystic fibrosis with severe pulmonary involvement].
    Hodson M.
    Arch Pediatr; 1995 Jul; 2(7):679-81. PubMed ID: 7663660
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.
    Aitken ML, Burke W, McDonald G, Shak S, Montgomery AB, Smith A.
    JAMA; 1992 Apr 08; 267(14):1947-51. PubMed ID: 1548827
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.